<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05122169</url>
  </required_header>
  <id_info>
    <org_study_id>Vaginal Delivery Skin Prep</org_study_id>
    <nct_id>NCT05122169</nct_id>
  </id_info>
  <brief_title>Prospective Study to Prevent Puerperal / Perinatal Infection in Vaginal Delivery</brief_title>
  <official_title>Prospective Study for Establishment of Clinical Practice Guideline to Prevent Puerperal / Perinatal Infection in Vaginal Delivery for Pregnant Women and Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, randomized, controlled trial study to find whether use of&#xD;
      chlorhexidine-alcohol or povidone-iodine for pre-vaginal delivery skin prep is superior to&#xD;
      reduce postpartum infection in pregnant women with vaginal delivery. The primary outcome is&#xD;
      the episiotomy site infection.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">May 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participant with episiotomy site infection</measure>
    <time_frame>21 days</time_frame>
    <description>Superficial or deep infection of episiotomy site</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">4140</enrollment>
  <condition>Vaginal Delivery</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>chlorhexidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pre-vaginal delivery skip prep using chlorhexidine-alcohol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Povidone-iodine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pre-vaginal delivery skip prep using Povidone-iodine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Povidone-Iodine</intervention_name>
    <description>Skin preparation with povidone-iodine pre-vaginal delivery skin preparation.</description>
    <arm_group_label>Povidone-iodine</arm_group_label>
    <other_name>Povidone-iodine 10%</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine</intervention_name>
    <description>Skin preparation with chlorhexidine-alcohol pre-vaginal delivery skin preparation.</description>
    <arm_group_label>chlorhexidine</arm_group_label>
    <other_name>Hexitanol 2% Soln., Chlorhexidine Gluconate Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women with singleton pregnancy&#xD;
&#xD;
          -  Women who will undergo vaginal delivery after 37+0/7 weeks of gestation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who are allergy to chlorhexidine, alcohol, iodine, or shellfish&#xD;
&#xD;
          -  Women with any infection at perineum (before vaginal delivery)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 8, 2021</study_first_submitted>
  <study_first_submitted_qc>November 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Joong Shin Park</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Chlorhexidine-alcohol</keyword>
  <keyword>Povidone-iodine</keyword>
  <keyword>Perineal infection</keyword>
  <keyword>Surgical site infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

